Symposia Overview and Topics

	Sat. Feb. 7	Sun. Feb. 8	Mon. Feb. 9	Tue. Feb. 10
AM
	Viral infections (#791)	Cancer risk factors (#891)	Synergistic therapies (#991)	Immunobiology (#1091)
	Genetic predisposition-i (#792)	Genetic predisposition-ii (#892)	Screening & detection (#992)	Screening & detection-ii (#1092)
	Dietary influences (#793)	Molecular pathology-i (#893)	Molecular pathology-ii (#993)	Molecular pathology-iii (#1093)
	Signaling pathways (#794)	Angiogenesis (#894)	Signaling pathways-ii (#994)	Metastasis inhibition (#1094)
	PM
		Apoptosis mechanisms (#795)	Chemotherapy response (#895)	Immunotherapy (#995)	Vaccines & surveillance (#1095)
Genetic instability (#796)		Suppressor genes (#896)	Genetics & environment (#996)	Cancer risk evaluation (#1096)
Cancer manifestation (#797)		Precursor lesions (#897)	Chemoprevention (#997)	Anticancer therapy (#1097)
Growth factor signaling (#798)		Oncogenesis (#898)	Signaling pathways-iii (#998)	(#1098)